Skip to main content

Acorda Therapeutics, Inc.

ACORDelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001008848

Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in Acorda Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
34
−2 vs. Q3 2021
Shares held
3.97M
+763.5K (+23.8%) vs. Q3 2021
Total value
$9.48M
−$5.26M (−35.7%) vs. Q3 2021
New holders
5
12 more added
Sold out
7
6 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 34 institutions
Q1 2021: 37 institutionsQ2 2021: 37 institutionsQ3 2021: 36 institutionsQ4 2021: 34 institutionsQ1 2022: 34 institutionsQ2 2022: 35 institutionsQ3 2022: 36 institutionsQ4 2022: 36 institutionsQ1 2023: 30 institutionsQ2 2023: 15 institutionsQ3 2023: 16 institutionsQ4 2023: 15 institutionsQ1 2024: 17 institutionsQ2 2024: 2 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $9.48M
Q1 2021: $18.0MQ2 2021: $18.1MQ3 2021: $14.7MQ4 2021: $9.48MQ1 2022: $5.42MQ2 2022: $3.08MQ3 2022: $1.91MQ4 2022: $4.09MQ1 2023: $3.71MQ2 2023: $1.94MQ3 2023: $2.30MQ4 2023: $2.33MQ1 2024: $2.13MQ2 2024: $8.00KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ACOR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20242$8.00K
Q1 202417$2.13M
Q4 202315$2.33M
Q3 202316$2.30M
Q2 202315$1.94M
Q1 202330$3.71M
Q4 202236$4.09M
Q3 202236$1.91M
Q2 202235$3.08M
Q1 202234$5.42M
Q4 202134$9.48M
Q3 202136$14.7M
Q2 202137$18.1M
Q1 202137$18.0M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding ACOR in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG17$00.00%−4,469−99.6%Reduced
JPMorgan Chase & Co8$00.00%00.0%Unchanged
First Manhattan Co50$00.00%00.0%Unchanged
IMA Wealth, Inc.17$00.00%00.0%Unchanged
JNBA Financial Advisors1$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.85$00.00%00.0%Unchanged
Private Capital Group, LLC10$00.00%+10New
Royal Bank of Canada895$3.00K0.00%+644+256.6%Added
Morgan Stanley5,061$11.0K0.00%+1,037+25.8%Added
Russell Investments Group, Ltd.6,000$14.0K0.00%00.0%Unchanged
Simplex Trading, LLC9,393$22.0K0.00%+9,393New
Citadel Advisors LLC14,455$35.0K0.00%+14,455New
HN Saltoro Capital, LP14,848$35.0K0.03%+14,848New
Two Sigma Advisers, LP17,300$41.0K0.00%+5,300+44.2%Added
Susquehanna Fundamental Investments, LLC22,600$54.0K0.00%−1,200−5.0%Reduced
Blair William & Co23,840$57.0K0.00%00.0%Unchanged
Northern Trust Corp26,118$62.0K0.00%−495−1.9%Reduced
United Asset Strategies, Inc.27,100$65.0K0.01%00.0%Unchanged
Bank of America Corp30,402$73.0K0.00%+10,975+56.5%Added
State Street Corp31,648$76.0K0.00%00.0%Unchanged
Dimensional Fund Advisors LP44,497$106.0K0.00%+2,641+6.3%Added
Geode Capital Management, LLC46,721$111.0K0.00%00.0%Unchanged
Wells Fargo & Company49,874$119.0K0.00%+49,682+25,876.0%Added
Invesco Ltd.77,868$186.0K0.00%−5,043−6.1%Reduced
Millennium Management LLC90,962$217.0K0.00%+50,241+123.4%Added
Federated Hermes, Inc.98,782$236.0K0.00%+297+0.3%Added
BlackRock Inc.166,678$399.0K0.00%+4,739+2.9%Added
Bridgeway Capital Management, LLC244,090$583.0K0.01%+103,500+73.6%Added
Highbridge Capital Management LLC282,193$674.0K0.02%+282,193New
Vanguard Group Inc341,545$817.0K0.00%00.0%Unchanged
Point72 Asset Management, L.P.464,276$1.11M0.00%−3,890−0.8%Reduced
Acadian Asset Management LLC467,739$1.12M0.00%+85,335+22.3%Added
Canyon Capital Advisors LLC649,031$1.55M0.05%+256,127+65.2%Added
Renaissance Technologies LLC714,156$1.71M0.00%−10,562−1.5%Reduced
AE Wealth Management LLC0$00.00%−40,457−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−35,850−100.0%Sold out
Apollon Wealth Management, LLC0$00.00%−15,000−100.0%Sold out
Two Sigma Investments, LP0$00.00%−10,855−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−1−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−6−100.0%Sold out
Cutler Group LP0$00.00%−117−100.0%Sold out